tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Le Berrigaud, 2 are a HOLD (28.57%), 5 are a BUY (71.43%).
Analyst Eric Le Berrigaud works at STIFEL with a stock forecast success ratio of 13.33% fulfilled within 52.2 days on average.
Eric Le Berrigaud’s has documented 23 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNY, Sanofi ADR at 30-Oct-2023.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 12/5/2022. The price target of $95 was fulfilled within 121 days with a profit of $7.83 (8.98%) receiving and performance score of 0.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
55
$5.99 (12.22%)
121.04
3 months 12 days ago
0/10 (0%)
$5.11 (10.24%)
Buy
115.07
$66.06 (134.79%)
101.24
3 months 27 days ago
0/3 (0%)
$63.08 (121.33%)
Buy
64
$14.99 (30.59%)
4 months 2 days ago
0/3 (0%)
$13.39 (26.46%)
Buy
56
$6.99 (14.26%)
55
5 months 20 days ago
0/8 (0%)
$10.58 (23.29%)
Buy
98.04
$49.03 (100.04%)
117.53
6 months 2 days ago
0/7 (0%)
$52.24 (114.06%)
What Year was the first public recommendation made by Eric Le Berrigaud?
